AI
By
Takeda Announces Positive Phase III Results for AI-Discovered Oral Psoriasis Therapy
Tokyo, Japan – December 19, 2025 – Takeda Pharmaceutical Company Limited today announced successful results from two Phase…
Geneva inaugurates first artificial intelligence health hub at Campus Biotech
GENEVA, Dec. 8, 2025 — Geneva has officially inaugurated its first artificial intelligence health hub at Campus Biotech,…
Cradle AI-powered protein engineering platform serving six of the top 25 global pharma leaders
AMSTERDAM and ZURICH, Dec. 16, 2025 — Cradle, an enterprise-grade AI software platform for protein engineering, today announced…
Adaptive Biotechnologies and Pfizer Announce Strategic Research Collaboration Valued Up to $890 Million to Advance Breakthrough Therapies for Rheumatoid Arthritis and Immune-Mediated Diseases
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis. A data licensing agreement to…
Pfizer Celebrates Innovation with 2025 AI Festival
Global – Pfizer hosted its second annual AI Festival Week, bringing together colleagues worldwide to explore the transformative…
Penguin AI Raises $29.7 Million to Transform Healthcare Administration with Advanced AI
Palo Alto, CA Penguin AI, a healthcare technology company focused on using artificial intelligence to reduce administrative burdens,…
